See more : CooTek (Cayman) Inc. (CTK) Income Statement Analysis – Financial Results
Complete financial analysis of Value Added Technology Co., Ltd. (043150.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Value Added Technology Co., Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- BioPlus Acquisition Corp. (BIOSW) Income Statement Analysis – Financial Results
- Marfrig Global Foods S.A. (MRRTY) Income Statement Analysis – Financial Results
- Dohwa Engineering Co., Ltd. (002150.KS) Income Statement Analysis – Financial Results
- Bluebik Group Public Company Limited (BBIK.BK) Income Statement Analysis – Financial Results
- GigCapital5, Inc. (GIA) Income Statement Analysis – Financial Results
Value Added Technology Co., Ltd. (043150.KQ)
About Value Added Technology Co., Ltd.
Value Added Technology Co., Ltd. develops, manufactures, and sells dental medical X-ray devices in Korea. It offers 2D, 3D, and intra oral imaging products. The company was founded in 1992 and is headquartered in Hwaseong, South Korea.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 384.95B | 395.06B | 338.98B | 244.31B | 271.70B | 234.39B | 218.81B | 178.56B | 217.36B | 194.79B | 171.52B | 175.81B |
Cost of Revenue | 179.77B | 197.49B | 179.32B | 137.24B | 149.57B | 125.19B | 115.45B | 104.19B | 119.96B | 108.22B | 97.87B | 112.83B |
Gross Profit | 205.18B | 197.57B | 159.66B | 107.07B | 122.13B | 109.21B | 103.36B | 74.37B | 97.40B | 86.57B | 73.65B | 62.98B |
Gross Profit Ratio | 53.30% | 50.01% | 47.10% | 43.82% | 44.95% | 46.59% | 47.24% | 41.65% | 44.81% | 44.44% | 42.94% | 35.82% |
Research & Development | 14.29B | 10.75B | 10.93B | 7.65B | 6.28B | 4.20B | 4.37B | 3.29B | 5.38B | 9.00B | 8.13B | 4.66B |
General & Administrative | 17.20B | 14.50B | 9.41B | 7.09B | 52.09B | 47.86B | 44.18B | 26.45B | 32.17B | 27.18B | 32.49B | 31.58B |
Selling & Marketing | 38.08B | 35.32B | 25.35B | 19.50B | 20.77B | 17.32B | 15.20B | 14.49B | 18.48B | 17.39B | 15.55B | 13.03B |
SG&A | 55.29B | 102.87B | 78.38B | 64.21B | 70.71B | 65.65B | 59.91B | 41.22B | 51.13B | 44.57B | 48.04B | 44.62B |
Other Expenses | 71.57B | -4.50B | -5.11B | -3.74B | -2.27B | -179.69M | -925.65M | -397.25M | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 141.14B | 118.12B | 94.42B | 75.60B | 79.26B | 70.03B | 65.21B | 44.91B | 56.51B | 72.38B | 68.62B | 52.56B |
Cost & Expenses | 320.96B | 315.61B | 273.74B | 212.85B | 228.83B | 195.22B | 180.66B | 149.11B | 176.47B | 180.60B | 166.49B | 165.39B |
Interest Income | 4.13B | 2.64B | 1.17B | 602.02M | 625.80M | 1.30B | 1.44B | 2.07B | 1.74B | 2.13B | 2.55B | 2.21B |
Interest Expense | 2.52B | 1.58B | 893.06M | 1.27B | 1.70B | 1.66B | 1.72B | 2.41B | 2.16B | 2.86B | 3.12B | 2.82B |
Depreciation & Amortization | 14.62B | 11.58B | 9.86B | 10.84B | 10.14B | 7.58B | 7.07B | 5.81B | 8.31B | 7.79B | 7.13B | 5.35B |
EBITDA | 83.87B | 91.22B | 75.39B | -10.18B | 53.01B | 46.93B | 42.54B | 35.74B | 45.99B | 39.44B | 22.44B | 17.76B |
EBITDA Ratio | 21.79% | 23.04% | 22.16% | 17.32% | 19.51% | 19.95% | 20.67% | 19.75% | 22.63% | 20.25% | 13.08% | 10.10% |
Operating Income | 64.04B | 79.45B | 65.24B | 31.47B | 42.87B | 39.17B | 38.15B | 29.45B | 40.89B | 31.64B | 15.31B | 12.40B |
Operating Income Ratio | 16.64% | 20.11% | 19.25% | 12.88% | 15.78% | 16.71% | 17.43% | 16.50% | 18.81% | 16.25% | 8.93% | 7.06% |
Total Other Income/Expenses | 2.69B | 2.94B | -1.08B | -55.28B | -3.84B | -1.14B | -4.46B | -2.33B | -5.47B | -19.46B | -12.84B | -4.19B |
Income Before Tax | 66.74B | 82.58B | 70.35B | -22.29B | 44.47B | 40.56B | 33.68B | 27.52B | 35.53B | 12.06B | 2.47B | 8.22B |
Income Before Tax Ratio | 17.34% | 20.90% | 20.75% | -9.12% | 16.37% | 17.31% | 15.39% | 15.41% | 16.34% | 6.19% | 1.44% | 4.67% |
Income Tax Expense | 13.77B | 18.95B | 18.85B | -1.90B | 12.58B | 11.41B | 8.82B | 6.71B | 6.81B | 442.86M | 638.63M | 2.57B |
Net Income | 51.73B | 76.89B | 51.24B | -24.22B | 33.88B | 27.26B | 79.09B | 24.77B | 21.29B | 9.70B | -6.58B | 6.37B |
Net Income Ratio | 13.44% | 19.46% | 15.11% | -9.91% | 12.47% | 11.63% | 36.14% | 13.87% | 9.80% | 4.98% | -3.84% | 3.62% |
EPS | 3.48K | 5.18K | 3.45K | -1.63K | 2.28K | 1.84K | 5.32K | 1.67K | 1.43K | 659.00 | -449.65 | 434.60 |
EPS Diluted | 3.48K | 5.18K | 3.45K | -1.63K | 2.28K | 1.84K | 5.32K | 1.67K | 1.43K | 659.00 | -449.65 | 434.60 |
Weighted Avg Shares Out | 14.85M | 14.85M | 14.85M | 14.85M | 14.85M | 14.85M | 14.85M | 14.85M | 14.85M | 14.72M | 14.64M | 14.66M |
Weighted Avg Shares Out (Dil) | 14.85M | 14.85M | 14.85M | 14.85M | 14.85M | 14.85M | 14.85M | 14.85M | 14.85M | 14.72M | 14.64M | 14.66M |
Source: https://incomestatements.info
Category: Stock Reports